fbpx Skip to main content
Category

OBGYN & Women’s Health

Close Menu

AADmember Follow

Official Twitter feed for members of the American Academy of Dermatology. News, info, and updates about the specialty and AAD meetings and events.

AADmember
aadmember AADmember @aadmember ·
23 Mar

“Keeping up with the indications and adverse reactions to immune checkpoint inhibitors can be a full-time job. Cutaneous side effects occur in up to 45% of patients treated with ipilimumab and 34% of patients treated with nivolumab and pembrolizumab.” https://bit.ly/3FGtxtd

Reply on Twitter 1638731563738472449 Retweet on Twitter 1638731563738472449 1 Like on Twitter 1638731563738472449 2 Twitter 1638731563738472449
aadmember AADmember @aadmember ·
22 Mar

.@spfnomt: This month’s #DermWorld article “Estate planning 101” is especially important for young physicians to read. The long, all-consuming years between adolescence and physicianhood can become a blur...https://bit.ly/3FxOtCv

Reply on Twitter 1638590867429629961 Retweet on Twitter 1638590867429629961 Like on Twitter 1638590867429629961 1 Twitter 1638590867429629961
Retweet on Twitter AADmember Retweeted
livnegris Olivia Negris @livnegris ·
21 Mar

That’s a wrap #AAD2023! 5 days of soaking up knowledge from dermatologists on topics such as hidradenitis, melasma, & dietary triggers of common dermatoses.

I LOVED the #womenshealth focused sessions on vulvar dermatoses and pregnancy medication safety.

#dermtwitter
@AADmember

Reply on Twitter 1638258107389210639 Retweet on Twitter 1638258107389210639 1 Like on Twitter 1638258107389210639 44 Twitter 1638258107389210639
aadmember AADmember @aadmember ·
22 Mar

New approach uses microbiome to treat skin disease by repairing the injured microbiome that allowed inflammation to flare up in the first place, rather than reducing the inflammation after the fact. https://bit.ly/3Jt6H9v

Reply on Twitter 1638545570519302146 Retweet on Twitter 1638545570519302146 1 Like on Twitter 1638545570519302146 3 Twitter 1638545570519302146
Load More